CHASTLETON MEDICAL GROUP
NEWTON DRIVE, DURHAM
CANCER 2
Cancer Reviewed since diagnosis
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CANCER 2 | 2005 | 75 | 95 | 78.9% | |
| CANCER 2 | 2006 | 119 | 137 | 86.9% | |
| CANCER 3 | 2007 | 49 | 49 | 100.0% | |
| CANCER 3 | 2008 | 35 | 36 | 97.2% | |
| CANCER 3 | 2009 | 41 | 44 | 93.2% | |
| CANCER 3 | 2010 | 41 | 44 | 93.2% | |
| CANCER 3 | 2011 | 48 | 53 | 90.6% | |
| CANCER 3 | 2012 | 52 | 57 | 91.2% | |
| CANCER 3 | 2013 | 51 | 55 | 92.7% | |
| CAN002 | 2014 | 70 | 79 | 88.6% | |
| CAN003 | 2015 | 60 | 66 | 90.9% | |
| CAN003 | 2016 | 59 | 66 | 89.4% | |
| CAN003 | 2017 | 48 | 59 | 81.4% | |
| CAN003 | 2018 | 53 | 62 | 85.5% | |
| CAN003 | 2019 | 62 | 67 | 92.5% | |
| CAN003 | 2020 | 65 | 71 | 91.5% | |
| CAN003 | 2021 | 56 | 72 | 77.8% | |
| CAN004 | 2022 | 78 | 81 | 96.3% | |
| CAN004 | 2023 | 77 | 78 | 98.7% |
